# We’re a Scrip Awards Finalist! 🏆 | Siren Biotechnology

- Canonical URL: https://wefunder.com/feed/193673
- Entity ID: wefunder:feed_item:193673
- Published at: 2025-10-02 17:50:51 UTC
- Updated at: 2025-10-06 15:07:36 UTC

## Author
Dr. Akela Kuwahara, PhD

## Subject
Siren Biotechnology

## Content
We’re excited to share that Siren is a finalist for the 2025 Scrip Innovation Award – a MAJOR honor in the biopharma world. For over 20 years, the Scrip Awards have spotlighted the most groundbreaking innovations in biotech and pharma. This year, we’re proud to be recognized among the boldest companies redefining what’s possible in medicine.🧬 What set us apart:A single gene therapy platform designed to treat many cancers - not just oneCurative results in 550+ animal models, including aggressive brain cancersFirst-of-its-kind AAV vector delivering engineered cytokines with precisionA world-class team from UCSF, Stanford, Duke, Mount Sinai, and RocheBacked by $28M from top-tier investors like Founders Fund and Lux CapitalThis recognition is a huge milestone as we gear up for clinical trials in 2026 and we’re just getting started! 🚨Our Wefunder round is closing soon!This is your chance to invest alongside Founders Fund, Lux Capital, Innovation Endeavors – and join us on this next chapter as we gear up for clinical trials and await the Scrip Awards ceremony in December.If you want to help us bring this therapy to the world, invest now →Or, if you’ve already joined us, increase your investment →Thank you for being part of the movement to build a better future for cancer care.— Akela (subbing in for Nicole today)